KYOTO -- A team led by Japanese biotech venture AnGes will ready production capacity for 1 million doses of coronavirus vaccines by March, a fivefold increase from the original plan, in order to ensure swift access to the domestic population.
AnGes-led team ramps up capacity while product is still under development

Takara Bio will produce more precursors for AnGes's coronavirus vaccine. (Photo courtesy of Takara Bio)
KYOTO -- A team led by Japanese biotech venture AnGes will ready production capacity for 1 million doses of coronavirus vaccines by March, a fivefold increase from the original plan, in order to ensure swift access to the domestic population.